Healthcare

[WEBINAR] Dealmaking 2026: What’s Changing, What’s Not, and How to Position for the Next Wave

Healthcare Events replay

[WEBINAR] Biopharma Dealmaking 2026: Trends, Shifts, and What Comes Next

In this webinar, Ipsos will frame the latest dealmaking trends using recent transactions and market data, followed by a moderated discussion with active investors on what is changing in valuation, deal structures, and decision criteria, and what this means for pharma acquirers and innovator biotechs preparing for partnering conversations.

05.19.26

Healthcare Publication

Insights For Pharma: Helping ‘Challenger’ Brands Win

Discover tips for how a “challenger” brand can make a mark, and ultimately win at launch...

11.10.21

Healthcare Survey

Americans rank mental health, cancer, drug abuse, and obesity as nation’s top health issues after COVID

Waiting times and lack of staff are perceived as the biggest problems with most countries’ healthcare system while cost of treatment tops the list in the U.S.: 2021 Global Health Service Monitor

10.25.21

Healthcare Publication

Oncology: the disease, dynamics & challenges of market research

The oncology treatment landscape rarely stands still, and its constant evolution affects all those involved: patients, their carers, cancer treaters, and treatment manufactures.

10.23.21

Public opinion Survey

While Americans view their mental and physical health as equally important, they don’t think the healthcare system does

30-country Ipsos survey for World Mental Health Day 2021 highlights wide age and gender gaps in how frequently people think about their mental health.

10.08.21

Healthcare Publication

Healthcare Cybersecurity Insights + Tips

Discover research examining the attitudes, concerns, and impacts on medical device security, as well as cybersecurity across large and midsize healthcare delivery organizations.

10.06.21

Healthcare Survey

Support for allowing the federal government to negotiate drug prices drops when Americans are presented with various arguments

A new PhRMA/Ipsos poll finds that Americans are worried about coverage costs in healthcare and prefer the federal government provide oversight and incentives to lower prices in the healthcare system over setting prices.

09.30.21